BioRestorative Therapies Inc.

(BRTX)

By |

Profile

BioRestorative Therapies Inc is a biotechnology company based in the US. It mainly develops therapeutic products and medical therapies using cell and tissue protocols, primarily involving adult (non-embryonic) stem cells. The company's development programs include Disc/Spine Program which involves cell therapy candidate, BRTX-100, a product formulated from autologous cultured mesenchymal stem cells, collected from the patient's bone marrow; and Metabolic Program which include development of a cell-based therapy to target obesity and metabolic disorders using brown adipose-derived stem cells, to generate brown adipose tissue.

Contact Information

Website: www.biorestorative.com
Main Phone: +1 631 760-8100
Address: 40 Marcus Drive
State: NY
City / Town: Melville
Country: USA
Postal Code: 11747

Issuer Information

Exchange: OTCQB
CEO: Mark Weinreb
Employees: 9
NAICS: Research and Development in Biotechnology (except Nanobiotechnology)(541714)
$ 0.66 $ 0.079 (13.60%)
Last Price 0.66 Change $ 0.079 Change % 13.60 Tick N/A
Bid N/A Bid Size N/A Ask N/A Ask Size N/A
Open 0.57 High 0.70 Low 0.55 Prev Close 0.58
Last Trade Volume 70,067 52 Wk Hi 4.00 52 Wk Low 0.50
Market Cap 6.9 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 10,453,936.00 EPS (TTM) -1.63 PE Ratio N/A Exchange OTCQB